Blackboxstocks Announces 271% Year-over-Year Revenue Increase for Q3 2020

Blackboxstocks Announces 271% Year-over-Year Revenue Increase for Q3 2020

YTD 2020 Subscriber Base Grew 260%: YTD 2020 Revenue Tops $2.3 Million

DALLAS–(BUSINESS WIRE)–
Blackboxstocks Inc. (OTC PINK: BLBX) (“Blackbox”), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders of all levels, today announced the Company’s financial results for the third quarter of 2020, ended September 30, 2020.

Third Quarter 2020 Highlights:

  • Total revenue for the third quarter of 2020 was $1,100,329, an increase of 271% over the same period in 2019.
  • Total revenue for the nine months ended September 30, 2020 was $2,324,428, an increase of 199% for the same period in 2019.
  • Income from operations for the third quarter of 2020 was $85,484 compared to a loss from operations of $247,482 for the same period in 2019.
  • The Subscriber Base grew 260% from January 1, 2020 to September 30, 2020.

Gust Kepler, CEO of Blackboxstocks, commented, “In the first nine months of 2020, our ongoing digital marketing initiatives have fueled expansion of our subscriber base by 260%, and driven revenue growth of 199%, including year-over-year growth of 271% in the third quarter alone. This growth trajectory has remained on the uptrend throughout the various phases of the COVID-19 lockdowns and re-openings, and the resulting market volatility. We anticipate an exciting fourth quarter with the market at an all-time high and the massive influx of young, first-time retail traders.”

Detailed financial information can be found in Blackboxstocks’ Quarterly Report on Form 10-Q for the period ended September 30, 2020 filed with the Securities Exchange Commission on November 16, 2020.

About Blackboxstocks, Inc.

Blackboxstocks, Inc. is a financial technology and social media hybrid platform offering real-time proprietary analytics and news for stock and options traders of all levels. Our web-based software employs “predictive technology” enhanced by artificial intelligence to find volatility and unusual market activity that may result in the rapid change in the price of a stock or option. Blackbox continuously scans the NASDAQ, New York Stock Exchange, CBOE, and all other options markets, analyzing over 8,000 stocks and up to 900,000 options contracts multiple times per second. We provide our users with a fully interactive social media platform that is integrated into our dashboard, enabling our users to exchange information and ideas quickly and efficiently through a common network. We recently introduced a live audio/video feature that allows our members to broadcast on their own channels to share trade strategies and market insight within the Blackbox community. Blackbox is a SaaS company with a growing base of users that spans 42 countries; current subscription fees are $99.97 per month or $959.00 annually. For more information, go to: www.blackboxstocks.com

Safe Harbor Statement

Our prospects here at Blackbox stocks are subject to uncertainties and risks. This press release contains forward-looking statements that involve substantial uncertainties and risks. These forward-looking statements are based upon our current expectations, estimates and projections about our business, and reflect our beliefs and assumptions based upon information available to us at the date of this press release. In some cases, you can identify these statements by words such as “if,” “may,” “might,” “will, “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue,” and other similar terms. These forward-looking statements include, among other things, plans for proposed operations, descriptions of our strategies, our product and market development plans, and other objectives, expectations and intentions, the trends we anticipate in our business and the markets in which we operate, and the competitive nature and anticipated growth of those markets. We caution readers that forward-looking statements are predictions based on our current expectations about future events. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Our actual results, performance or achievements could differ materially from those expressed or implied by the forward-looking statements as a result of a number of factors including, but not limited to, the risks and uncertainties discussed in our other filings with the Securities Exchange Commission. We undertake no obligation to revise or update any forward-looking statement for any reason.

[email protected]


PCG Advisory

Stephanie Prince, Managing Director

(646) 762-4518

[email protected]

KEYWORDS: Texas United States North America

INDUSTRY KEYWORDS: Professional Services Communications Technology Social Media Finance Software

MEDIA:

Daniel Yergin, IHS Markit Vice Chairman, Named “Energy Writer of the Year” by American Energy Society for His New Book, The New Map: Energy, Climate and the Clash of Nations

Daniel Yergin, IHS Markit Vice Chairman, Named “Energy Writer of the Year” by American Energy Society for His New Book, The New Map: Energy, Climate and the Clash of Nations

WASHINGTON–(BUSINESS WIRE)–
IHS Markit Vice Chairman Daniel Yergin has been named “Energy Writer of the Year” for his new book, The New Map: Energy, Climate and the Clash of Nations (Penguin Press; U.S. edition / UK edition). The award is presented by the American Energy Society, a non-partisan, independent network of nearly 135,000 professionals from every energy sector.

In bestowing the award, the American Energy Society said that The New Map “earned energy’s highest literary prize for its ambitious survey and realistic assessment of energy and how it shapes all of human affairs. It is also an exceptional literary triumph in its narrative and in the quality of writing that we have come to expect from Dan Yergin.”

Eric Vettel, President of American Energy Society said of this year’s award: “Mr. Yergin’s legendary contributions to the field, highlighted with the release of The New Map, made this year’s selection obvious. We selected him as the Energy Writer of the Year for his intellectual approach, his balanced treatment of competing ideas, his extraordinary grasp of an enormous subject, his methodical defense of an ambitious thesis with massive amounts of data, his masterful storytelling skills and in recognition of a lifetime of literary achievement.”

Upon receiving the award, Yergin said: “I am deeply honored to receive the distinguished award of ‘Energy Writer of the Year’ from the American Energy Society. Energy’s unique ability to touch every aspect of our collective lives and influence the course of history, as well as shape the future, has been a perpetual focus throughout my career—a fascination that I have always striven to share in my writings. To be recognized with this award from the American Energy Society, with its commitment to engaging the widest cross-section of stakeholders in the energy world, is a singular honor.”

Read the complete American Energy Society award announcement here: https://www.energysociety.org/ewoty2020.html

In The New Map, Yergin looks at how the global COVID-19 pandemic brought new complexity and disruption to an energy world already being reshaped by myriad forces—from the remarkable change in the energy position of the United States in the middle of a contentious presidential election, to geopolitical tension with China and Russia, to the reappearance of the electric car, the growing global role of renewables and the “post-Paris” era of energy transition.

“As a result of the pandemic, an uncharted chasm has suddenly appeared on the map, which the world is now beginning to work its way around,” Yergin writes.

“This is no simple map to follow, for it is dynamic, constantly changing as major countries chart intersecting and sometimes conflicting geopolitical paths in a new era of great power competition,” he adds.

Additional Praise for The New Map:

A “wonderful book on the transformation of the global map of power and wealth.” – Sunday Times (London)

“Brisk and authoritative, an impressive combination.” The Economist

“Reportorial and supremely readable—no mean feat among geostrategy tomes.” Wall Street Journal

“At a time when solid facts and reasoned arguments are in retreat, Daniel Yergin rides to the rescue…. Yergin provides an engaging survey course on the lifeblood of modern civilization — where the world has been and where it is likely headed. By the final page, the reader will feel like an energy expert herself.”USA Today

“Yergin delivers a fascinating and meticulously researched page-turner…. Required reading. Another winner from a master.” Kirkus, Starred Review

About Daniel Yergin:

Daniel Yergin is a highly respected authority on energy, international politics and economics, and a Pulitzer Prize winner. He is Vice Chairman of IHS Markit, one of the leading information and advisory firms in the world with 16,000 employees worldwide.

Time Magazine said, “If there is one man whose opinion matters more than any other on global energy markets, it’s Daniel Yergin.” Fortune said that he is “one of the planet’s foremost thinkers about energy and its implications.”

A Pulitzer Prize winner, his latest book, The New Map: Energy, Climate, and the Clash of Nations, was designated by Kirkus as “required reading. Another winner from a master.”

Dr. Yergin is the author of the bestseller The Quest: Energy, Security, and the Remaking of the Modern World. The Quest has been described by the Financial Times as “a triumph.” The New York Times said it is “necessary reading for C.E.O.’s, conservationists, lawmakers, generals, spies, tech geeks, thriller writers,” among many others.

Bill Gates summed up his review of The Quest by saying, “This is a fantastic book.”

Dr. Yergin is known around the world for his book The Prize: The Epic Quest for Oil Money and Power, which was awarded the Pulitzer Prize. It became a number one New York Times best seller and has been translated into 20 languages.

Of Dr. Yergin’s book Commanding Heights: The Battle for the World Economy, which has been translated into 13 languages, The Wall Street Journal said, “No one could ask for a better account of the world’s political and economic destiny since World War II.”

Both The Prize and Commanding Heights were made into award-winning television documentaries for PBS, BBC and Japan’s NHK.

Dr. Yergin has served on the U.S. Secretary of Energy Advisory Board under the last four presidents. He is a member of the Energy Policy Council of the Dallas Federal Reserve.

Dr. Yergin was awarded the United States Energy Award for “lifelong achievements in energy and the promotion of international understanding.” The International Association for Energy Economics honored Dr. Yergin for “outstanding contributions to the profession of energy economics and to its literature.”

Dr. Yergin is a director of the Council on Foreign Relations and a senior trustee of the Brookings Institution. He is a member of the Advisory Boards of the Massachusetts Institute of Technology Energy Initiative and of the Columbia University Center on Global Energy Policy and of Singapore’s International Energy Advisory Board.

Dr. Yergin holds a BA from Yale University, where he founded The New Journal, and a PhD from Cambridge University, where he was a Marshall Scholar.

Follow Daniel Yergin on Twitter: @DanielYergin

For interview requests and media inquiries contact:

IHS Markit: Jeff Marn, [email protected]

Penguin Press: Liz Calamari (U.S.), [email protected] or Penelope Vogler (UK), [email protected]

About IHS Markit(www.ihsmarkit.com)

IHS Markit (NYSE: INFO) is a world leader in critical information, analytics and solutions for the major industries and markets that drive economies worldwide. The company delivers next-generation information, analytics and solutions to customers in business, finance and government, improving their operational efficiency and providing deep insights that lead to well-informed, confident decisions. IHS Markit has more than 50,000 business and government customers, including 80 percent of the Fortune Global 500 and the world’s leading financial institutions. Headquartered in London, IHS Markit is committed to sustainable, profitable growth.

IHS Markit is a registered trademark of IHS Markit Ltd. and/or its affiliates. All other company and product names may be trademarks of their respective owners © 2020 IHS Markit Ltd. All rights reserved.

Jeff Marn

IHS Markit

+1 202 463 8213

[email protected]

Press Team

+1 303 858 6417

[email protected]

KEYWORDS: District of Columbia United States North America

INDUSTRY KEYWORDS: Entertainment Other Energy Oil/Gas Alternative Energy Energy Books

MEDIA:

Logo
Logo

Bank of America Is First Authorized Participant to Leverage ICE’s FIX API for Creations and Redemptions

Bank of America Is First Authorized Participant to Leverage ICE’s FIX API for Creations and Redemptions

ATLANTA & NEW YORK–(BUSINESS WIRE)–
Intercontinental Exchange, Inc. (NYSE:ICE), a leading operator of global exchanges and clearing houses and provider of mortgage technology, data and listings services, today announced that Bank of America became the first authorized participant to leverage ICE ETF Hub’s FIX API to communicate ETF share creations and redemptions. This is an important milestone in the ETF industry’s adoption of ICE ETF Hub, which was designed as an industry-wide, open architecture, technology solution, offering a more standardized and simplified process for the creation and redemption of ETF shares.

ICE launched a FIX (Financial Information eXchange) application programming interface (API) earlier this year that allows authorized participants to connect to the ICE ETF Hub platform and seamlessly and automatically manage their creations and redemptions.

“Creations and redemptions for ETFs have traditionally been very complicated and required market participants to use a variety of tools to agree to baskets,” said J. Kevin McCarthy, Managing Director and Head of BofA Securities Financing and Clearing. “ICE ETF Hub is the first platform to offer FIX access to issuers and authorized participants, which provides an end-to-end, fully electronic workflow between Bank of America’s order management system and ETF issuers’ platforms.”

ICE ETF Hub’s custom basket negotiation technology allows primary market participants to negotiate and assemble custom basket proposals in an automated environment. ICE Chat functionality was also recently launched to support communication throughout the custom basket workflow.

“We continue to believe that the standardization and automation of the ETF primary market will lead to greater efficiencies for market participants and convenience for investors,” said Samara Cohen, Co-Head of ETF and Index Investing, BlackRock. “The FIX API provides the infrastructure to modernize and scale the creation and redemption process by connecting ETF authorized participants, market makers and custodians in a seamless, automated workflow. We are excited to see further progress and adoption by the industry, including the inception of a dedicated ETF working group at the FIX Trading Organization to help accelerate standardization across the ETF ecosystem.”

“We’re excited to see our vision for automating and simplifying the ETF creation and redemption process come to life, and to continue working with the ETF community to bring further innovation to help transform the primary market,” said Peter Borstelmann, President of ICE Bonds and Head of ICE ETF Hub.

ICE ETF Hub currently supports both U.S.-listed domestic equity and fixed income ETFs. For more information about ICE ETF Hub, please visit: www.theice.com/etf-hub.

About Intercontinental Exchange

Intercontinental Exchange (NYSE: ICE) is a Fortune 500 company and provider of marketplace infrastructure, data services and technology solutions to a broad range of customers including financial institutions, corporations and government entities. We operate regulated marketplaces, including the New York Stock Exchange, for the listing, trading and clearing of a broad array of derivative contracts and financial securities across major asset classes. Our comprehensive data services offering supports the trading, investment, risk management and connectivity needs of customers around the world and across asset classes. As a leading technology provider, ICE Mortgage Technology provides the technology and infrastructure to transform and digitize U.S. residential mortgages, from application and loan origination through to final settlement.

Trademarks of ICE and/or its affiliates include Intercontinental Exchange, ICE, ICE block design, NYSE and New York Stock Exchange. Information regarding additional trademarks and intellectual property rights of Intercontinental Exchange, Inc. and/or its affiliates is located at http://www.intercontinentalexchange.com/terms-of-use. Key Information Documents for certain products covered by the EU Packaged Retail and Insurance-based Investment Products Regulation can be accessed on the relevant exchange website under the heading “Key Information Documents (KIDS).”

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 — Statements in this press release regarding ICE’s business that are not historical facts are “forward-looking statements” that involve risks and uncertainties. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see ICE’s Securities and Exchange Commission (SEC) filings, including, but not limited to, the risk factors in ICE’s Annual Report on Form 10-K for the year ended December 31, 2019, as filed with the SEC on February 6, 2020.

ICE-CORP

ICE Media Contact:

Damon Leavell

[email protected]

212-323-8587

ICE Investor Contact:

Warren Gardiner

[email protected]

770-835-0114

KEYWORDS: North Carolina New York Georgia United States North America

INDUSTRY KEYWORDS: Professional Services Data Management Technology Finance Software Banking

MEDIA:

Logo
Logo

GlobalPost Introduces GlobalPost Plus SmartSaver Service Allowing Shippers to Reduce Delivery Delays to Canada, UK and Mexico

GlobalPost Introduces GlobalPost Plus SmartSaver Service Allowing Shippers to Reduce Delivery Delays to Canada, UK and Mexico

EL SEGUNDO, Calif.–(BUSINESS WIRE)–GlobalPost, the industry leader in affordable, innovative international shipping services, today announced the launch of GlobalPost Plus SmartSaver service for online retailers. GlobalPost Plus SmartSaver is a fast, low-cost international shipping alternative for high volume shippers that fulfill 30 or more packages per day and includes prepaid duties and taxes for parcels going to UK, Mexico and Canada. The service includes features not found in traditional international shipping services. These features include allowing users to process heavier packages up to 66 lbs., send products up to $2,500 in value and ship without customs forms.

GlobalPost Plus SmartSaver includes advanced customs clearance, with shipments usually clearing customs electronically often before the shipment arrives in the destination country. This process helps expedite the delivery process, allowing the shipment to quickly be delivered to the buyer.

The GlobalPost Plus SmartSaver service offers online retailers these great benefits:

  • A Better Customer Experience: With sellers paying the duties and taxes, the buyer receives a smooth and easy delivery experience.
  • Decreased Returns: Shipments that arrive without duties paid face a high rate of refusal, or abandonment, as unhappy consumers refuse to pay the additional costs. When customers refuse a package, the seller typically has to pay the return shipping fees to get the package back.
  • Increased Sales Conversion: GlobalPost Plus SmartSaver is designed to help online sellers improve their shopping cart conversion rate. If duties/taxes are not included in the website checkout, there’s a higher chance for cart abandonment because the buyer can’t anticipate the cost of the customer’s fees. By including duties/taxes as a shipping option, sellers may experience a much higher cart conversion rate.

Getting deliveries from the U.S. to international customers quickly and reliably is the goal for all online retailers. GlobalPost Plus SmartSaver makes international shipping a lot easier,” said Ken McBride, Chairman and CEO of Stamps.com, the GlobalPost parent company. “GlobalPost Plus SmartSaver reduces hassle, increases peace of mind and helps get orders into the hands of online buyers in Canada, Mexico and the UK a lot faster.”

GlobalPost Overview

The GlobalPost delivery network leverages partnerships with international postal operators as well as commercial carriers to offer worldwide delivery. GlobalPost services reach over 200 countries and territories and includes unique features not found in traditional international shipping service

About Stamps.com

Stamps.com (NASDAQ: STMP) is the leading provider of postage online and shipping software solutions to customers including consumers, small businesses, e-commerce shippers, enterprises, and high volume shippers. Stamps.com offers solutions that help businesses run their shipping operations more smoothly and function more successfully under the brand names Stamps.com, Endicia®, ShipStation®, ShipEngine®, ShippingEasy®, ShipWorks®, GlobalPost and Metapack™. Stamps.com’s family of brands provides seamless access to mailing and shipping services through integrations with more than 500 unique partner applications.

Investor Contact:

Stamps.com Investor Relations

(310) 482-5830

[email protected]

Press Contact:

Eric Nash

Stamps.com Public Relations

(310) 482-5942

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Software Online Technology Online Retail Logistics/Supply Chain Management Transport Retail Entertainment

MEDIA:

Logo
Logo

Chesterfield County Public Schools Engineers Solution to Pandemic Problem with Citrix®

Chesterfield County Public Schools Engineers Solution to Pandemic Problem with Citrix®

District implements digital workspace technology to keep STEM labs running, students learning

FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–
COVID-19 has forced schools around the world to think outside the box when it comes to educating students. And Chesterfield County Public Schools (CCPS) has risen to the occasion. Leveraging digital workspace solutions from Citrix Systems, Inc. (NASDAQ:CTXS), the district is providing the more than 5,000 students enrolled in its Career and Technical Education (CTE) programs with secure and reliable access to the systems and software they need to excel while learning remote.

“Meeting the needs of all students during the pandemic required Chesterfield Schools to identify a solution to extend specialized computer-based learning to the home environment,” said Brian Jones, Executive Director of Technology Services, CCPS. “Waiting until students could return to their CTE labs was not an option.”

A Flexible Approach

But the district realized it would face some unique challenges in finding the right offering. The STEM-based curriculum taught as part of the district’s CTE programs relies heavily on memory and compute-intensive software run on CAD stations set up in labs across 12 schools.

“This isn’t software that can be loaded onto your average PC,” said Achim Purdy, Network Manager, CCPS. “And without access to the high-powered machines on which it is run, students can’t effectively learn.”

Facing the same plight, many districts across the country opted to suspend their STEM programs until students can return to classrooms fulltime. CCPS chose a different route.

A Powerful Solution

Like the more than 400,000 companies around the world using Citrix digital workspace solutions to power the flexible work models that COVID-19 demands, the district chose to implement Citrix® Virtual Apps and Desktops™ Service and Citrix Remote PC Access™ to deliver a familiar virtual desktop from which CTE students can safely access all the resources they need to learn and a high-performance experience that enables them to excel from home.

And in less than two weeks, it had achieved its goal.

“With Citrix, students can quickly and easily connect to the CAD stations they use in our labs from their school-issued Chromebooks” Purdy said. “Everything looks the same and is delivered in a reliable way so they can just focus and do their best work.”

CCPS joins hundreds of educational institutions using Citrix solutions to power a better way to learn. To find out more about these solutions and the value they can deliver, visit: https://www.citrix.com/solutions/education/

About CCPS

Chesterfield County Public Schools is the public school system of Chesterfield County, Virginia and serves more than 63,000 students across 39 elementary schools (grades K-5), 12 middle schools (grades 6-8), and 11 high schools (grades 9-12.) Additionally, high school students can enroll in 13 specialty centers, two technical centers, and two Governor’s Schools. For more information, visit https://mychesterfieldschools.com

About Citrix

Citrix (NASDAQ:CTXS) is powering a better way to work with unified workspace, networking, and analytics solutions that help organizations unlock innovation, engage customers, and boost productivity, without sacrificing security. With Citrix, users get a seamless work experience and IT has a unified platform to secure, manage, and monitor diverse technologies in complex cloud environments. Citrix solutions are in use by more than 400,000 organizations including 98 percent of the Fortune 500.

For Citrix Investors:

This release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and of Section 21E of the Securities Exchange Act of 1934. The forward-looking statements in this release do not constitute guarantees of future performance. Those statements involve a number of factors that could cause actual results to differ materially, including risks associated with the impact of the global economy and uncertainty in the IT spending environment, revenue growth and recognition of revenue, products and services, their development and distribution, product demand and pipeline, economic and competitive factors, the Company’s key strategic relationships, acquisition and related integration risks as well as other risks detailed in the Company’s filings with the Securities and Exchange Commission. Citrix assumes no obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein. The development, release and timing of any features or functionality described for our products remains at our sole discretion and is subject to change without notice or consultation. The information provided is for informational purposes only and is not a commitment, promise or legal obligation to deliver any material, code or functionality and should not be relied upon in making purchasing decisions or incorporated into any contract.

© 2020 Citrix Systems, Inc. Citrix, the Citrix logo, and other marks appearing herein are the property of Citrix Systems, Inc. and may be registered with the U.S. Patent and Trademark Office and in other countries. All other marks are the property of their respective owners.

Karen Master

Citrix

+1 216-396-4683

[email protected]

KEYWORDS: United States North America Florida Virginia

INDUSTRY KEYWORDS: Hardware Technology Primary/Secondary Software Education

MEDIA:

Logo
Logo

Barnes & Noble Education Announces Fiscal 2021 Second Quarter Earnings Release Date and Conference Call Webcast

Barnes & Noble Education Announces Fiscal 2021 Second Quarter Earnings Release Date and Conference Call Webcast

BASKING RIDGE, N.J.–(BUSINESS WIRE)–Barnes & Noble Education, Inc. (NYSE: BNED) today announced the Company expects to report fiscal 2021 second quarter earnings results on Tuesday, December 8, 2020 before the market opens. The Company will host an investor conference call at 8:30 a.m. Eastern Time on Tuesday, December 8, 2020 to review the Company’s financial results and operations.

This call is being webcast and can be accessed at Barnes & Noble Education’s corporate website at www.bned.com. The webcast of this call will be archived and available for three months on Barnes & Noble Education’s corporate website.

ABOUT BARNES & NOBLE EDUCATION, INC.

Barnes & Noble Education, Inc. (NYSE: BNED) is a leading solutions provider for the education industry, driving affordability, access and achievement at hundreds of academic institutions nationwide and ensuring millions of students are equipped for success in the classroom and beyond. Through its family of brands, BNED offers campus retail services and academic solutions, a digital direct-to-student learning ecosystem, wholesale capabilities and more. BNED is a company serving all who work to elevate their lives through education, supporting students, faculty and institutions as they make tomorrow a better, more inclusive and smarter world. For more information, visit www.bned.com.

Media:

Carolyn J. Brown

Senior Vice President

Corporate Communications and Public Affairs

Barnes & Noble Education, Inc.

(908) 991-2967

[email protected]

Investors:

Andy Milevoj

Vice President

Corporate Finance and Investor Relations

Barnes & Noble Education, Inc.

(908) 991-2776

[email protected]

KEYWORDS: New Jersey United States North America

INDUSTRY KEYWORDS: Publishing Continuing Communications University Primary/Secondary Books Education Entertainment

MEDIA:

Logo
Logo

Veracyte Announces New General Manager Structure to Advance Global Expansion

Veracyte Announces New General Manager Structure to Advance Global Expansion

John Hanna appointed GM, endocrinology, breast cancer and lymphoma;

Morten Frost to join company as GM, pulmonology

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Veracyte (Nasdaq: VCYT) today announced a new general manager-based structure to advance the company’s growing roster of genomic tests and its global expansion. John Hanna, currently chief commercial officer, will become GM, endocrinology, breast cancer and lymphoma. The company also announced that Morten Frost will join the company as GM, pulmonology. Both executives will assume their new roles January 1, 2021.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201117005508/en/

John Hanna appointed GM, endocrinology, breast cancer and lymphoma, at Veracyte

John Hanna appointed GM, endocrinology, breast cancer and lymphoma, at Veracyte

“Veracyte is undergoing exciting growth, including our transformation into a global diagnostics company, our growing menu of genomic tests in a range of diseases, and our planned launch next year of four new products,” said Bonnie Anderson, Veracyte’s chairman and chief executive officer. “Our new GM-based structure will optimally position us to serve our growing customer base, manage our products throughout their life cycles to ensure long-term strategic growth and further empower our executive leaders and employees throughout the organization.”

The new general managers will have global responsibility and accountability for their respective indications from strategic business planning to tactical execution, including pipeline development, strategy, marketing, sales, reimbursement and field-based medical affairs.

John Hanna will continue to drive growth for Veracyte’s flagship Afirma business in thyroid cancer and will assume leadership over the company’s growing global Prosigna business in breast cancer, which together represent approximately 90 percent of revenue today. He will also lead the company’s lymphoma business, with the launch of its LymphMark subtyping test scheduled for next year. Mr. Hanna joined Veracyte in 2011 and has held several leadership roles during his tenure. Since he became chief commercial officer in 2017, the company’s genomic test volume and revenue have doubled.

Morten Frost will join Veracyte to lead its lung cancer portfolio strategy, including the launch next year of the company’s nasal swab test and Percepta Atlas, and will also drive the global introduction in 2021 of the Envisia classifier, for use in interstitial lung disease diagnosis, on the nCounter Analysis System. Mr. Frost comes to Veracyte with significant strategic consulting, sales and marketing experience. He was most recently at Agilent Technologies, where he served as head of global marketing for the company’s pathology and companion diagnostics business, which are part of Agilent’s approximately $1 billion Diagnostics and Genomics Group. In this role, he drove significant revenue growth, global product launches, biopharmaceutical partnerships and M&A strategy.

“I could not be more pleased to have executives of John’s and Morten’s caliber leading our product businesses at this exciting moment in our company’s growth,” said Ms. Anderson. “John’s leadership has been critical to Veracyte’s success to date and will be key to further driving revenue growth across multiple indications in the United States and globally. I am also thrilled that Morten is joining Veracyte to further strengthen our leadership team. He is an exceptional market strategist who will be critical to driving our pulmonology business forward, particularly in lung cancer, where we estimate our current and pipeline products target an addressable market of approximately $40 billion.”

About Veracyte

Veracyte (Nasdaq: VCYT) is a global genomic diagnostics company that improves patient care by providing answers to clinical questions, informing diagnosis and treatment decisions throughout the patient journey in cancer and other diseases. The company’s growing menu of genomic tests leverage advances in genomic science and technology, enabling patients to avoid risky, costly diagnostic procedures and quicken time to appropriate treatment. The company’s tests in thyroid cancer, lung cancer, breast cancer and idiopathic pulmonary fibrosis are available to patients and its lymphoma subtyping test is in development. With Veracyte’s exclusive global license to a best-in-class diagnostics instrument platform, the company is positioned to deliver its tests to patients worldwide. Veracyte is based in South San Francisco, California. For more information, please visit www.veracyte.com and follow the company on Twitter (@veracyte).

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements, including, but not limited to, our statements related to our plans, objectives, expectations (financial and otherwise) and intentions. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “expect,” “believe,” “should,” “may,” “will” and similar references to future periods. Actual results may differ materially from those projected or suggested in any forward-looking statements. These statements involve risks and uncertainties, which could cause actual results to differ materially from our predictions. Factors that may impact these forward-looking statements can be found in Item 1A – “Risk Factors” in our Annual Report on Form 10-K filed with the SEC on February 25, 2020 and in our Quarterly Report on Form 10-Q filed with the SEC on November 2, 2020. A copy of these documents can be found at the Investors section of our website at www.veracyte.com. These forward-looking statements speak only as of the date hereof and Veracyte specifically disclaims any obligation to update these forward-looking statements or reasons why actual results might differ, whether as a result of new information, future events or otherwise.

Veracyte, Afirma, Percepta, Envisia, Prosigna, “Know by Design” and the Veracyte, Afirma, Percepta, Envisia and Prosigna logos are registered trademarks in the U.S. and selected countries. We have common law rights and pending trademark applications for LymphMark and “More About You.”

nCounter is the registered trademark of NanoString Technologies, Inc. in the United States and other countries and used by Veracyte under license.

Investor and Media Contact:

Tracy Morris

Vice President of Corporate Communications

& Investor Relations

650-380-4413

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Oncology Health Technology Genetics Software Pharmaceutical Biotechnology

MEDIA:

Logo
Logo
Photo
Photo
John Hanna appointed GM, endocrinology, breast cancer and lymphoma, at Veracyte
Photo
Photo
Morten Frost appointed GM, Pulmonology, at Veracyte

Bristol Myers Squibb Completes Acquisition of MyoKardia, Strengthening Company’s Leading Cardiovascular Franchise

Bristol Myers Squibb Completes Acquisition of MyoKardia, Strengthening Company’s Leading Cardiovascular Franchise

NEW YORK–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE:BMY) announced today that it has successfully completed its acquisition of MyoKardia, Inc. in an all cash transaction for approximately $13.1 billion. With the completion of the acquisition, MyoKardia shares have ceased trading on the NASDAQ Global Select Market and MyoKardia is now a wholly-owned subsidiary of Bristol Myers Squibb.

“We are excited to welcome MyoKardia colleagues to Bristol Myers Squibb. The MyoKardia team has revolutionized cardiovascular treatments to address significant unmet medical needs, and we look forward to helping more patients together,” said Giovanni Caforio, M.D., Board Chair and Chief Executive Officer of Bristol Myers Squibb. “With MyoKardia, we are bolstering our leading cardiovascular franchise and adding exceptional scientific capabilities, a potentially transformative new medicine with significant commercial potential and a promising pipeline of candidates. Cardiovascular remains an important therapeutic area for Bristol Myers Squibb with a strong legacy and a promising future.”

Through the transaction with MyoKardia, Bristol Myers Squibb gains mavacamten, a potential first-in-class cardiovascular medicine for the treatment of obstructive hypertrophic cardiomyopathy (“HCM”), a chronic heart disease with high morbidity and patient impact. A New Drug Application (“NDA”) for mavacamten for the treatment of symptomatic obstructive HCM – based on data from the EXPLORER-HCM study – is expected to be submitted to the U.S. Food and Drug Administration in the first quarter of 2021. Bristol Myers Squibb expects to explore the full potential of mavacamten in additional indications, including non-obstructive HCM, as well as develop MyoKardia’s promising pipeline of novel compounds, including two clinical-stage therapeutics: danicamtiv (formerly MYK-491) and MYK-224, and two pre-clinical assets: ACT-1 and LUS-1.

Bristol Myers Squibb’s previously announced tender offer for all outstanding shares of common stock of MyoKardia for $225.00 per share expired at 12:00 a.m. New York City time, at the end of the day on November 16, 2020. Approximately 42,180,978 shares of MyoKardia common stock were validly tendered, and not withdrawn from the tender offer, representing approximately 78.9% of MyoKardia’s outstanding shares of common stock. In accordance with the terms of the tender offer, all shares that were validly tendered and not properly withdrawn have been accepted for payment and Bristol Myers Squibb expects to promptly pay for all such shares.

Following completion of the tender offer, Bristol Myers Squibb completed the acquisition of MyoKardia through the merger of Gotham Merger Sub Inc. with and into MyoKardia, without a vote of MyoKardia’s stockholders pursuant to Section 251(h) of the General Corporation Law of the State of Delaware. As a result of the merger, each share of common stock of MyoKardia issued and outstanding and not tendered in the tender offer was converted into the right to receive an amount in cash equal to $225.00, without interest and less any required withholding taxes, the same price offered in the tender offer.

MyoKardia shareholders can direct questions regarding the tender offer to MacKenzie Partners, Inc., the information agent for the tender offer, toll free, at 1-800-322-2885.

About Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is a chronic, progressive disease in which excessive contraction of the heart muscle and reduced ability of the left ventricle to fill can lead to the development of debilitating symptoms and cardiac dysfunction. HCM is estimated to affect one in every 500 people.

The most frequent cause of HCM is mutations in the heart muscle proteins of the sarcomere. In approximately two-thirds of HCM patients, the path followed by blood exiting the heart, known as the left ventricular outflow tract (LVOT), becomes obstructed by the enlarged and diseased muscle, restricting the flow of blood from the heart to the rest of the body (obstructive HCM). In other patients, the thickened heart muscle does not block the LVOT, and their disease is driven by diastolic impairment due to the enlarged and stiffened heart muscle (non-obstructive HCM). In either obstructive or non-obstructive HCM patients, exertion can result in fatigue or shortness of breath, interfering with a patient’s ability to participate in activities of daily living. HCM has also been associated with increased risks of atrial fibrillation, stroke, heart failure and sudden cardiac death.

There are currently approximately 160,000 to 200,000 people diagnosed with symptomatic obstructive HCM across the U.S. and EU, with no existing effective treatment options beyond limited symptomatic relief.Patients are typically diagnosed in their 40s or 50s and the treatment is expected to be chronic. It is estimated that only approximately 25 percent of individuals with obstructive HCM and only approximately 10 percent of individuals with non-obstructive HCM have received a diagnosis.

Advisors

Gordon Dyal & Co., LLC is serving as exclusive financial advisor to Bristol Myers Squibb, and Kirkland & Ellis LLP is serving as legal counsel. Centerview Partners LLC and Guggenheim Securities are acting as joint financial advisors to MyoKardia and Goodwin Procter LLP is serving as legal counsel.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

Cautionary Statement Regarding Forward Looking Statements

This press release contains “forward-looking statements” relating to the acquisition of MyoKardia by Bristol Myers Squibb and the development and commercialization of certain biological compounds. Such forward-looking statements are generally identified by terminology such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other similar words. These statements are only predictions, and such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including factors that could delay, divert or change any of them, and could cause actual outcomes and results to differ materially from current expectations. No forward-looking statement can be guaranteed. Among other risks are (i) that there can be no guarantee that the expected benefits of the acquisition will be realized, (ii) the outcome of any legal proceedings that may be instituted against the parties and others related to the merger agreement and (iii) unanticipated difficulties or expenditures relating to the transaction, the response of business partners and competitors to the transaction and/or potential difficulties in employee retention as a result of the transaction. The actual financial impact of this transaction may differ from the expected financial impact described in this press release. In addition, the compounds described in this press release are subject to all the risks inherent in the drug development process, and there can be no assurance that the development of these compounds will be commercially successful. Forward-looking statements in this press release should be evaluated together with the many uncertainties that affect Bristol Myers Squibb’s business, particularly those identified in the cautionary factors discussion in Bristol Myers Squibb’s Annual Report on Form 10-K for the year ended December 31, 2019, and its subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, as well as other documents that may be filed by Bristol Myers Squibb from time to time with the SEC. Bristol Myers Squibb does not undertake any obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. The forward-looking statements made in this communication relate only to events as of the date on which the statements are made.

corporatefinancial-news

Media:

[email protected]

Investors:

Tim Power, 609-252-7509, [email protected]

Nina Goworek, 908-673-9711, [email protected]

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Biotechnology Health Pharmaceutical Clinical Trials Cardiology

MEDIA:

Logo
Logo

MVB Financial Corp. Commences Modified Dutch Auction Tender Offer to Repurchase up to $45.0 Million of its Common Stock

MVB Financial Corp. Commences Modified Dutch Auction Tender Offer to Repurchase up to $45.0 Million of its Common Stock

FAIRMONT, W. Va.–(BUSINESS WIRE)–
MVB Financial Corp. (NASDAQ: MVBF) (“MVB” or the “Company”) announced today that it has commenced a modified “Dutch auction” tender offer (the “Tender Offer”) to purchase, for cash, up to $45.0 million of its common stock (the “Common Stock”) at a price per share not less than $18.00 and not greater than $20.25, less any applicable withholding taxes and without interest. The Company intends to purchase the shares using available cash on hand and proceeds from an anticipated private placement of subordinated notes to certain institutional accredited investors. On November 16, 2020, the closing price of the Common Stock was $18.50 per share. The Tender Offer will expire at 5:00 p.m., New York City time, at the end of the day on December 18, 2020, unless extended or terminated.

If the Tender Offer is fully subscribed, the Company will purchase between 2,222,222 shares and 2,500,000 shares, or between 18.8% and 21.2%, respectively, of the outstanding Common Stock as of November 5, 2020. Any shares tendered may be withdrawn prior to expiration of the Tender Offer. Stockholders that do not wish to participate in the Tender Offer do not need to take any action. The Company is pursuing the Tender Offer in part as a means to provide a return of capital option to existing investors as the Company continues to evolve its primary business strategy from a traditional community banking model to a technology driven financial services provider. None of our directors or executive officers will tender any of their shares in the Tender Offer.

A modified “Dutch auction” tender offer allows stockholders to indicate how many shares of Common Stock and at what price within the range described above they wish to tender their shares. Based on the number of shares tendered and the prices specified by the tendering stockholders, the Company will determine the lowest per-share price that will enable it to acquire up to $45.0 million of Common Stock. All shares accepted in the Tender Offer will be purchased at the same price even if tendered at a lower price.

To tender shares of Common Stock, stockholders must follow the instructions described in the “Offer to Purchase” and the “Letter of Transmittal” that the Company is filing with the U.S. Securities and Exchange Commission (“SEC”). These documents contain important information about the terms and conditions of the Tender Offer.

The Tender Offer will not be contingent upon any minimum number of shares being tendered. The Tender Offer will, however, be subject to other conditions, which will be disclosed in the Offer to Purchase. The Company’s Board of Directors (the “Board”) believes that a modified “Dutch auction” tender offer is an efficient mechanism that will provide all stockholders with the opportunity to tender all or a portion of their shares. In the future, the Board may consider additional tender offer(s) or other measures to enhance stockholder value based on a variety of factors, including the market price of the Common Stock.

The Board has authorized the Tender Offer. However, none of the Company, the Board, the dealer manager, the information agent, the depositary or any of their respective affiliates are making any recommendation to stockholders as to whether to tender or refrain from tendering their shares in the Tender Offer or as to the price at which stockholders may choose to tender their shares. No person is authorized to make any such recommendation. Stockholders must decide how many shares they will tender, if any, and the price within the stated range at which they will offer their shares for purchase. In doing so, stockholders should read carefully the information in, or incorporated by reference in, the Offer to Purchase and the Letter of Transmittal (as they may be amended or supplemented), including the purposes and effects of the Tender Offer. It is recommended that Stockholders discuss their decisions with their own tax advisors, financial advisors and/or brokers.

Raymond James & Associates, Inc. is acting as dealer manager for the Tender Offer. The information agent for the Tender Offer is Georgeson LLC, and the depositary is Computershare Trust Company, N.A. The Offer to Purchase, the Letter of Transmittal and related documents will be mailed to registered holders. Beneficial holders will receive the Offer to Purchase and a communication from their bank, broker or custodian. For questions and information, please call the information agent toll-free at (800) 733-6198.

Certain Information Regarding the Tender Offer

The information in this press release describing the Tender Offer is for informational purposes only and does not constitute an offer to buy or the solicitation of an offer to sell shares of Common Stock in the Tender Offer or an offer to sell or the solicitation of an offer to purchase any new securities. The Tender Offer is being made only pursuant to the Offer to Purchase and the related materials that the Company is filing with the SEC, and will distribute to its stockholders, as such materials may be amended or supplemented. Stockholders should read such Offer to Purchase and related materials carefully and in their entirety because they contain important information, including the various terms and conditions of the Tender Offer. Stockholders of the Company may obtain a free copy of the Tender Offer statement on Schedule TO, the Offer to Purchase and other documents that the Company is filing with the SEC from the SEC’s website at www.sec.gov. Stockholders also will be able to obtain a copy of these documents, without charge, from Georgeson LLC, the information agent for the Tender Offer, toll free at (800) 733-6198 or Raymond James & Associates, Inc. at (312) 655-2964. Stockholders should carefully read all of these materials prior to making any decision with respect to the Tender Offer. Stockholders and investors who have questions or need assistance may call Georgeson LLC toll free at (800) 733-6198.

About MVB Financial Corp.

MVB Financial Corp., the holding company of MVB Bank, Inc., is publicly traded on The Nasdaq Capital Market® (“Nasdaq”) under the ticker “MVBF.” Nasdaq is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its subsidiary, MVB Bank, Inc., and its subsidiaries, MVB Community Development Corporation, Chartwell Compliance and Paladin, the Company provides financial services to individuals and corporate clients in the Mid-Atlantic region and beyond. Chartwell Compliance is one of the world’s leading specialist firms in state and federal compliance and market entry facilitation for firms entering into or expanding in North America, serving many of the most high-profile providers of the Fintech industry. For more information about MVB, please visit http://ir.mvbbanking.com.

Forward-looking Statements

The Company has made forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, in this Press Release. These forward-looking statements are based on current expectations about the future and subject to risks and uncertainties. Forward-looking statements include, without limitation, information concerning possible or assumed future results of operations of the Company and its subsidiaries. When words such as “may,” “plans,” “believes,” “expects,” “anticipates,” “continues,” “may” or similar expressions occur in this Press Release, the Company is making forward-looking statements. Note that many factors could affect the future financial results of the Company and its subsidiaries, both individually and collectively, and could cause those results to differ materially from those expressed in the forward-looking statements contained in this Press Release. Those factors include but are not limited to: the possibility that shareholders will not be receptive to the Tender Offer; the Company’s ability to consummate the Tender Offer or the related financing necessary to generate proceeds to fund the Tender Offer on favorable terms, changes in general market, economic, tax, regulatory or industry conditions that impact the ability or willingness of the Company to consummate the above-described transactions on the terms described above or at all; credit risk; changes in market interest rates; length and severity of the recent COVID-19 (coronavirus) outbreak and its impact on the Company’s business and financial condition; economic downturn or recession; and government regulation and supervision. Additional factors that may cause actual results to differ materially from those described in the forward-looking statements can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, as well as its other filings with the SEC, which are available on the SEC website at www.sec.gov. Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements.

MEDIA CONTACT

Amy Baker

VP, Corporate Communications and

Marketing

MVB Financial Corp.

[email protected]

(844) 682-2265

INVESTOR RELATIONS

Marcie Lipscomb

[email protected]

(844) 682-2265

KEYWORDS: United States North America West Virginia

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

Logo
Logo

Granite Earned Designation as a Great Place to Work-Certified™ Company in 2020

Granite Earned Designation as a Great Place to Work-Certified™ Company in 2020

WATSONVILLE, Calif.–(BUSINESS WIRE)–
Granite (GVA) announced that it is a Great Place to Work-Certified™ company by Great Place to Work®, the global authority on workplace culture, employee experience and the leadership behaviors proven to deliver market-leading revenue and increased innovation. Certification is a significant achievement based on validated employee feedback gathered with Great Place to Work’s rigorous, data-driven For All™ methodology.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201117005409/en/

“It is our honor to be Great Place to Work-Certified™ for the third time,” said Granite President Kyle Larkin. “Our people define Granite’s culture and create the type of environment where people respect and feel respected by their peers and leaders, and take pride in their work. This certification belongs to each and every member of the Granite team.”

“We congratulate Granite, on their Certification,” said Sarah Lewis-Kulin, Vice President of Best Workplace List Research at Great Place to Work. “Organizations that earn their employees’ trust create great workplace cultures that deliver outstanding business results.”

About Granite

Granite is America’s Infrastructure Company™. Incorporated since 1922, Granite (NYSE:GVA) is one of the largest diversified construction and construction materials companies in the United States as well as a full-suite provider in the transportation, water infrastructure and mineral exploration markets. Granite’s Code of Conduct and strong Core Values guide the Company and its employees to uphold the highest ethical standards. In addition to being one of the World’s Most Ethical Companies for eleven consecutive years, Granite is an industry leader in safety and an award-winning firm in quality and sustainability. For more information, visit graniteconstruction.com, and connect with Granite on LinkedIn, Twitter, Facebook and Instagram.

About Great Place to Work®

Great Place to Work® is the global authority on workplace culture. Since 1992, they have surveyed more than 100 million employees around the world and used those deep insights to define what makes a great workplace: trust. Great Place to Work helps organizations quantify their culture and produce better business results by creating a high-trust work experience for all employees. Emprising®, their culture management platform, empowers leaders with the surveys, real-time reporting, and insights they need to make data-driven people decisions. Their unparalleled benchmark data is used to recognize Great Place to Work-Certified™ companies and the Best Workplaces™ in the US and more than 60 countries, including the 100 Best Companies to Work For® and World’s Best list published annually in Fortune. Everything they do is driven by the mission to build a better world by helping every organization become a Great Place to Work For All™.

To learn more, visit greatplacetowork.com, listen to the podcast Better by Great Place to Work, and read “A Great Place to Work for All.” Join the community on LinkedIn, Twitter, and Instagram.

Media

Erin Kuhlman 831-768-4111

Investors

Lisa Curtis 831-728-7532

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Other Construction & Property Residential Building & Real Estate Commercial Building & Real Estate Construction & Property Urban Planning

MEDIA:

Logo
Logo
Photo
Photo